Dimitrios Gogos

Proliferation and bone marrow engraftment of AML blasts is dependent on β‐catenin signalling

Elena K. Siapati, M. Papadaki, Zoi Kozaou et al. · British Journal of Haematology · 2010 · 43 citations

Life Sciences, Cell Biology, Hematology +17

Chronic myelomonocytic leukemia treated with 5-azacytidine – results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system

Panagiotis Diamantopoulos, Ιoannis Kotsianidis, Argiris Symeonidis et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2018 · 25 citations

Medicine, Hematology, Oncology +15

Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes

Sotirios G. Papageorgiou, Ιoannis Kotsianidis, Anthi Bouchla et al. · Therapeutic Advances in Hematology · 2020 · 24 citations · Full text

Medicine, Hematology, Oncology +13

Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival

Eirini Katodritou, Marie‐Christine Kyrtsonis, Sosana Delimpasi et al. · Annals of Hematology · 2018 · 20 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

High levels of serum angiogenic growth factors in patients with AL amyloidosis: comparisons with normal individuals and multiple myeloma patients

Efstathios Kastritis, Michalis Michael, Maria Gavriatopoulou et al. · British Journal of Haematology · 2010 · 12 citations · Full text

Medicine, Cardiology, Internal Medicine +14